Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
Silver Spring, Maryland, United States
Disclosure information not submitted.
Pharmacovigilance and Signal Detection
Thursday, August 25, 2022
8:30 AM – 12:30 PM CEST